Concepedia

Pavel Yamanushkin

PY

6

Publications

91

Citations

6

H-Index

2010

Active since

Affiliations

Chemical Diversity Research Institute(Current)

ChemDiv (United States)

Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences

Moscow Institute of Physics and Technology

Pavel Yamanushkin is an author at Chemical Diversity Research Institute specializing in pharmacology, biomolecular engineering, and medicine.

ORCID

Top concepts

Publications per year

2010–2022

6

Publications

6

Novel oral anti-influenza drug candidate AV5080

Alexandre V. Ivachtchenko, Yan A. Ivanenkov, Oleg D. Mitkin et al. · Journal of Antimicrobial Chemotherapy · 2014 · 21 citations

A novel influenza virus neuraminidase inhibitor AV5027

Alexandre V. Ivachtchenko, Yan A. Ivanenkov, Oleg D. Mitkin et al. · Antiviral Research · 2013 · 17 citations

, , +1

SuFExable <i>NH</i>-Pyrazoles via 1,3-Dipolar Cycloadditions of Diazo Compounds with Bromoethenylsulfonyl Fluoride

Pavel Yamanushkin, Kemal Kaya, Mark Aldren M. Feliciano et al. · The Journal of Organic Chemistry · 2022 · 17 citations · Full text

Discovery of Novel Highly Potent Hepatitis C Virus NS5A Inhibitor (AV4025)

Alexandre V. Ivachtchenko, Oleg D. Mitkin, Pavel Yamanushkin et al. · Journal of Medicinal Chemistry · 2014 · 14 citations · Full text

, , +15

Bromination of indomethacin

Alexandre V. Ivachtchenko, Pavel Yamanushkin, Oleg D. Mitkin · Mendeleev Communications · 2010 · 12 citations

Rows per page

1–5 of 6